Zacks: Brokerages Anticipate MedEquities Realty Trust Inc (MRT) Will Post Quarterly Sales of $16.93 Million

Analysts expect that MedEquities Realty Trust Inc (NYSE:MRT) will report $16.93 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for MedEquities Realty Trust’s earnings. The lowest sales estimate is $16.76 million and the highest is $17.10 million. MedEquities Realty Trust reported sales of $14.83 million in the same quarter last year, which indicates a positive year over year growth rate of 14.2%. The business is scheduled to announce its next earnings results on Tuesday, August 14th.

According to Zacks, analysts expect that MedEquities Realty Trust will report full-year sales of $69.09 million for the current fiscal year, with estimates ranging from $69.07 million to $69.10 million. For the next financial year, analysts forecast that the firm will post sales of $77.99 million per share, with estimates ranging from $76.40 million to $79.58 million. Zacks’ sales averages are a mean average based on a survey of research analysts that follow MedEquities Realty Trust.

MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings data on Thursday, May 10th. The financial services provider reported $0.16 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.14). The company had revenue of $16.72 million for the quarter, compared to the consensus estimate of $16.41 million. MedEquities Realty Trust had a net margin of 34.63% and a return on equity of 6.17%.

A number of brokerages recently weighed in on MRT. Royal Bank of Canada restated a “sector perform” rating and set a $11.00 price objective (down previously from $12.00) on shares of MedEquities Realty Trust in a research report on Wednesday, May 23rd. B. Riley set a $13.00 price objective on shares of MedEquities Realty Trust and gave the company a “buy” rating in a research report on Monday, May 14th. KeyCorp lowered their price objective on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Monday, April 16th. ValuEngine cut shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Finally, JMP Securities set a $13.00 target price on shares of MedEquities Realty Trust and gave the company a “buy” rating in a report on Friday, May 11th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the stock. MedEquities Realty Trust currently has a consensus rating of “Hold” and a consensus price target of $12.25.

Shares of MedEquities Realty Trust stock opened at $10.59 on Friday. The company has a market cap of $338.00 million, a P/E ratio of 9.29 and a beta of -0.12. MedEquities Realty Trust has a twelve month low of $9.67 and a twelve month high of $13.06.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 5th. Shareholders of record on Tuesday, May 22nd were issued a dividend of $0.21 per share. The ex-dividend date of this dividend was Monday, May 21st. This represents a $0.84 dividend on an annualized basis and a yield of 7.93%. MedEquities Realty Trust’s dividend payout ratio is currently 73.68%.

In other MedEquities Realty Trust news, Director Bluemountain Capital Managemen sold 24,739 shares of the company’s stock in a transaction that occurred on Tuesday, May 1st. The shares were sold at an average price of $10.17, for a total transaction of $251,595.63. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders have sold 363,688 shares of company stock valued at $3,756,271. 2.50% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in MRT. Schwab Charles Investment Management Inc. increased its stake in shares of MedEquities Realty Trust by 69.2% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 776,946 shares of the financial services provider’s stock worth $8,718,000 after purchasing an additional 317,829 shares in the last quarter. LSV Asset Management purchased a new stake in shares of MedEquities Realty Trust in the fourth quarter worth $103,000. Victory Capital Management Inc. increased its stake in shares of MedEquities Realty Trust by 18.0% in the fourth quarter. Victory Capital Management Inc. now owns 142,160 shares of the financial services provider’s stock worth $1,595,000 after purchasing an additional 21,700 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of MedEquities Realty Trust by 93.1% in the fourth quarter. Wells Fargo & Company MN now owns 68,306 shares of the financial services provider’s stock worth $767,000 after purchasing an additional 32,940 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. increased its stake in shares of MedEquities Realty Trust by 89.0% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 25,012 shares of the financial services provider’s stock worth $281,000 after purchasing an additional 11,778 shares in the last quarter. 93.53% of the stock is owned by hedge funds and other institutional investors.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply